Theratechnologies Stock Market Value
THTX Stock | USD 1.21 0.03 2.54% |
Symbol | Theratechnologies |
Theratechnologies Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Theratechnologies. If investors know Theratechnologies will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Theratechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share 1.865 | Quarterly Revenue Growth 0.084 | Return On Assets 0.1176 | Return On Equity (11.17) |
The market value of Theratechnologies is measured differently than its book value, which is the value of Theratechnologies that is recorded on the company's balance sheet. Investors also form their own opinion of Theratechnologies' value that differs from its market value or its book value, called intrinsic value, which is Theratechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Theratechnologies' market value can be influenced by many factors that don't directly affect Theratechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Theratechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theratechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theratechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Theratechnologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Theratechnologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Theratechnologies.
10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Theratechnologies on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Theratechnologies or generate 0.0% return on investment in Theratechnologies over 30 days. Theratechnologies is related to or competes with Opthea, Centessa Pharmaceuticals, Nuvalent, Tarsus Pharmaceuticals, Genfit, Verrica Pharmaceuticals, and Inventiva. Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapi... More
Theratechnologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Theratechnologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Theratechnologies upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.06) | |||
Maximum Drawdown | 21.28 | |||
Value At Risk | (3.94) | |||
Potential Upside | 5.04 |
Theratechnologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Theratechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Theratechnologies' standard deviation. In reality, there are many statistical measures that can use Theratechnologies historical prices to predict the future Theratechnologies' volatility.Risk Adjusted Performance | (0) | |||
Jensen Alpha | (0.16) | |||
Total Risk Alpha | (0.59) | |||
Treynor Ratio | (0.07) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Theratechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Theratechnologies Backtested Returns
At this stage we consider Theratechnologies Stock to be slightly risky. Theratechnologies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0041, which indicates the firm had a 0.0041% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Theratechnologies, which you can use to evaluate the volatility of the company. Please validate Theratechnologies' Coefficient Of Variation of (6,911), variance of 10.19, and insignificant Risk Adjusted Performance to confirm if the risk estimate we provide is consistent with the expected return of 0.0133%. The entity has a beta of 0.85, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Theratechnologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding Theratechnologies is expected to be smaller as well. Theratechnologies right now has a risk of 3.22%. Please validate Theratechnologies value at risk, as well as the relationship between the rate of daily change and relative strength index , to decide if Theratechnologies will be following its existing price patterns.
Auto-correlation | 0.07 |
Virtually no predictability
Theratechnologies has virtually no predictability. Overlapping area represents the amount of predictability between Theratechnologies time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Theratechnologies price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Theratechnologies price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.07 | |
Spearman Rank Test | 0.19 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Theratechnologies lagged returns against current returns
Autocorrelation, which is Theratechnologies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Theratechnologies' stock expected returns. We can calculate the autocorrelation of Theratechnologies returns to help us make a trade decision. For example, suppose you find that Theratechnologies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Theratechnologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Theratechnologies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Theratechnologies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Theratechnologies stock over time.
Current vs Lagged Prices |
Timeline |
Theratechnologies Lagged Returns
When evaluating Theratechnologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Theratechnologies stock have on its future price. Theratechnologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Theratechnologies autocorrelation shows the relationship between Theratechnologies stock current value and its past values and can show if there is a momentum factor associated with investing in Theratechnologies.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Theratechnologies Stock Analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.